|
medpundit |
||
 |
 |
|
Sunday, November 21, 2004McKillop proposed that the industry should adopt a system of conditional approval, whereby new drugs would be closely monitored for side effects after receiving their initial marketing licence. McKillop said this could prevent some of the controversies that have battered the pharmaceutical industry in recent years. It would prevent innovative — and therefore potentially risky — new medicines being indiscriminately prescribed by inexpert general practitioners. Does that mean they'll drop direct to consumer advertising for these new drugs? And detailing by sales reps? And by the way, the number one prescribers of Crestor, Astra-Zeneca's controversial new cholesterol medicine, are cardiologists, at least in my geographical area. They're giving it out like it was candy. posted by Sydney on 11/21/2004 12:13:00 AM 0 comments 0 Comments: |
|
